Skip to content

Bioresolutions

Active Risk: not assessed
Private limited companyfounded 20205 yrs activeKruishoutemstraat 57, 9870 Zulte, BelgiumKBO/BCE: BE 0758.934.037
Summary

Bioresolutions is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €213,564 and a net result of -€4,068. Equity remains stable across the filed fiscal years (±0.7% per year). Its solvency ranks better than 95% of 8061 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
1 d early
2024
15 d early
2023
on the day
2022
35 d early
2021
41 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 18 days before the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 1 December 2020, Bioresolutions was incorporated as a Private limited company.1 Total assets went from EUR 299,495 in 2021 to EUR 219,616 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2021 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€213,564▼ 10.1%
2024 · €237,632
Net result
-€4,068▲ 49.4%
2024 · -€8,042
Total assets
€219,616▼ 9.4%
2024 · €242,371
Solvency
97.2%▼ 0.8pp
2024 · 98.0%
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€211,096-€90,993▼ 56.9%€2,048▼ 97.7%-€9,099-€3,703▲ 59.3%
Net result€162,398-€71,756▼ 55.8%€521▼ 99.3%-€8,042-€4,068▲ 49.4%
Equity€173,398-€245,153▲ 41.4%€245,674▲ 0.2%€237,632▼ 3.3%€213,564▼ 10.1%
Total assets€299,495-€287,551▼ 4.0%€255,918▼ 11.0%€242,371▼ 5.3%€219,616▼ 9.4%
Debt€126,097-€42,397▼ 66.4%€10,243▼ 75.8%€4,739▼ 53.7%€6,052▲ 27.7%
Working capital€159,106-€220,940▲ 38.9%€221,936▲ 0.5%€210,130▼ 5.3%€178,448▼ 15.1%
Solvency57.9%-85.3%▲ 27.4pp96.0%▲ 10.7pp98.0%▲ 2.0pp97.2%▼ 0.8pp
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€100,000€0€100,000€200,000Operating result 2021: €211,096€211,096Net result 2021: €162,398€162,398Operating result 2022: €90,993€90,993Net result 2022: €71,756€71,756Operating result 2023: €2,048€2,048Net result 2023: €521€521Operating result 2024: -€9,099-€9,099Net result 2024: -€8,042-€8,042Operating result 2025: -€3,703-€3,703Net result 2025: -€4,068-€4,06820212022202320242025-€10,000-€5,000€0Operating result 2023: €2,048€2,050Net result 2023: €521€521Operating result 2024: -€9,099-€9,100Net result 2024: -€8,042-€8,040Operating result 2025: -€3,703-€3,700Net result 2025: -€4,068-€4,070202320242025
The operating result stays negative: a loss of €3,703 in 2025 against €9,099 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €219,616
Fixed assets €35,116 ▲ 28.6%
Current assets €184,500 ▼ 14.1%
Equity and liabilities €219,616
Equity €213,564 ▼ 10.1%
Debt €6,052 ▲ 27.7%
Debt's share of the balance-sheet total rises from 2.0% to 2.8%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
ROE
-1.9%▲
2024 · -3.4%
ROA
-1.9%▲
2024 · -3.3%
Debt ≤ 1 year
€6,052▲
2024 · €4,739
Income taxes
€132▼
2024 · €140
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 49 lines
Balance sheet Code20242025
Assets
Total assets20/58€242,371€219,616▼
Formation expenses20€189€0▼
Fixed assets21/28€27,313€35,116▲
Tangible fixed assets22/27€6,378€14,181▲
Plant, machinery and equipment23€1,482€1,274▼
Furniture and vehicles24€4,896€12,907▲
Financial fixed assets28€20,934€20,934=
Current assets29/58€214,869€184,500▼
Amounts receivable after more than one year29€70,000€110,000▲
Trade receivables290€70,000€110,000▲
Amounts receivable within one year40/41€27,634€13,487▼
Trade receivables40€6,042€6,274▲
Other amounts receivable41€21,592€7,213▼
Current investments50/53€32,400€32,400=
Cash at bank and in hand54/58€82,162€27,035▼
Deferred charges and accrued income490/1€2,673€1,578▼
Equity and liabilities
Total equity and liabilities10/49€242,371€219,616▼
Equity10/15€237,632€213,564▼
Contributions10/11€11,000€11,000=
Reserves13€226,632€206,632▼
Distributable reserves133€226,632€206,632▼
Profit (loss) carried forward14--€4,068
Amounts payable17/49€4,739€6,052▲
Amounts payable within one year42/48€4,739€6,052▲
Financial debts43€17€0▼
Credit institutions430/8€17€0▼
Trade debts44€3,530€673▼
Suppliers440/4€3,530€673▼
Taxes, remuneration and social security45€1,193€165▼
Taxes450/3€1,193€165▼
Other amounts payable47/48-€5,215
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,904€2,911▲
Other operating charges640/8€705€951▲
Gross operating margin9900-€5,491€159▲
Operating profit (loss)9901-€9,099-€3,703▲
Financial income75/76B€1,413€0▼
Recurring financial income75€1,413€0▼
Financial charges65/66B€216€233▲
Recurring financial charges65€216€233▲
Profit (loss) for the period before taxes9903-€7,903-€3,936▲
Income taxes67/77€140€132▼
Profit (loss) for the period9904-€8,042-€4,068▲
Profit (loss) for the period to be appropriated9905-€8,042-€4,068▲
Appropriation of the result
Profit (loss) to be appropriated9906-€8,042-€4,068▲
Transfer from equity791/2€8,042€20,000▲
Transfer to equity691/2€0-
To other reserves6921€0-
Profit to be distributed694/7-€20,000
Return on contributions (dividend)694-€20,000

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€268€1,477€2,458€2,904€2,911▲ 0.3%
Other operating charges640/8€745€1,090€1,331€705€951▲ 34.9%
Gross operating margin9900€212,109€93,560€5,837-€5,491€159▲ 103%
Operating profit (loss)9901€211,096€90,993€2,048-€9,099-€3,703▲ 59.3%
Financial income75/76B€0-€1€1,413€0▼ 100%
Recurring financial income75€0-€1€1,413€0▼ 100%
Financial charges65/66B€32€381€206€216€233▲ 7.6%
Recurring financial charges65€32€381€206€216€233▲ 7.6%
Profit (loss) for the period before taxes9903€211,064€90,612€1,843-€7,903-€3,936▲ 50.2%
Income taxes67/77€48,666€18,856€1,323€140€132▼ 5.4%
Profit (loss) for the period9904€162,398€71,756€521-€8,042-€4,068▲ 49.4%
Profit (loss) for the period to be appropriated9905€162,398€71,756€521-€8,042-€4,068▲ 49.4%
Line20212022202320242025Change
Assets
Total assets20/58€299,495€287,551€255,918€242,371€219,616▼ 9.4%
Formation expenses20€812€604€397€189€0▼ 100%
Fixed assets21/28€13,480€23,752€23,342€27,313€35,116▲ 28.6%
Tangible fixed assets22/27€4,480€9,484€9,074€6,378€14,181▲ 122%
Plant, machinery and equipment23-€1,899€1,691€1,482€1,274▼ 14.1%
Furniture and vehicles24€4,480€7,585€7,384€4,896€12,907▲ 164%
Financial fixed assets28€9,000€14,267€14,267€20,934€20,934=
Current assets29/58€285,203€263,195€232,179€214,869€184,500▼ 14.1%
Amounts receivable after more than one year29---€70,000€110,000▲ 57.1%
Trade receivables290---€70,000€110,000▲ 57.1%
Amounts receivable within one year40/41€182,468€2,609€8,855€27,634€13,487▼ 51.2%
Trade receivables40€182,468--€6,042€6,274▲ 3.9%
Other amounts receivable41-€2,609€8,855€21,592€7,213▼ 66.6%
Current investments50/53--€32,400€32,400€32,400=
Cash at bank and in hand54/58€101,356€258,636€187,755€82,162€27,035▼ 67.1%
Deferred charges and accrued income490/1€1,379€1,950€3,169€2,673€1,578▼ 41.0%
Equity and liabilities
Total equity and liabilities10/49€299,495€287,551€255,918€242,371€219,616▼ 9.4%
Equity10/15€173,398€245,153€245,674€237,632€213,564▼ 10.1%
Contributions10/11€11,000€11,000€11,000€11,000€11,000=
Reserves13€162,398€234,153€234,674€226,632€206,632▼ 8.8%
Distributable reserves133€162,398€234,153€234,674€226,632€206,632▼ 8.8%
Profit (loss) carried forward14-----€4,068-
Amounts payable17/49€126,097€42,397€10,243€4,739€6,052▲ 27.7%
Amounts payable within one year42/48€126,097€42,255€10,243€4,739€6,052▲ 27.7%
Financial debts43€2,195€20€928€17€0▼ 100%
Credit institutions430/8€2,195€20€928€17€0▼ 100%
Trade debts44€3,496€14,837€1,592€3,530€673▼ 80.9%
Suppliers440/4€3,496€14,837€1,592€3,530€673▼ 80.9%
Advances received on contracts in progress46--€0---
Taxes, remuneration and social security45€115,095€27,397€7,723€1,193€165▼ 86.2%
Taxes450/3€113,095€27,397€7,723€1,193€165▼ 86.2%
Remuneration and social security454/9€2,000-----
Other amounts payable47/48€5,312---€5,215-
Accrued charges and deferred income492/3-€143€0---
Line20212022202320242025Change
Profit (loss) for the period9904€162,398€71,756€521-€8,042-€4,068▲ 49.4%
+ Depreciation and write-downs630€268€1,477€2,458€2,904€2,911▲ 0.3%
Operating cash flow (approximation)€162,666€73,233€2,979-€5,139-€1,157▲ 77.5%
Investment in fixed assets (approximation)--€11,748-€2,048-€6,874-€10,714▼ 55.9%
Change in cash-€157,280-€70,881-€105,593-€55,127▲ 47.8%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
16-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Weakest financial yearnet -€8,042
Net result drops to -€8,042, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity doublescurrent ratio 45.34
Current ratio from 22.67 to 45.34; short-term debt falls from €10,243 to €4,739.
31-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Liquidity quadruplescurrent ratio 22.67
Current ratio from 6.23 to 22.67; short-term debt falls from €42,255 to €10,243.
26-06
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Liquidity triplescurrent ratio 6.23
Current ratio from 2.26 to 6.23; short-term debt falls from €126,097 to €42,255.
31-12
Financial Equity above €200,000Eq €245,153 ▲41.4%
2 profitable years in a row build equity to €245,153.
20-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zulte · 1 establishment unit since 2020
seat establishment The establishment unit on the map
Ground area
1,067 m²
Building footprint
151 m²
Volume, LiDAR
913 m³
Parcel 44037B0657/00G000, Flanders · tallest building 6.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Bioresolutions
Kruishoutemstraat 57, 9870 ZulteHoldings
since 20202.310.191.887
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44037B0657/00G000 Flanders 1,067 m² 1 · 151 m² 6.9 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 31-12-2024 list no shareholders, and no other source names one.

Holdings 1

According to the 2024 annual accounts of Bioresolutions and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 24,729 companies in sector 64210 we hold annual accounts for 19,773. 13,544 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded01-12-2020
Fiscal year end31-12
Activities, NACEBEL 2025
64210Activities of holding companies
70200Business and other management consultancy
73300Public relations and communication consultancy
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0758934037
Also 9925:BE0758934037
Registered 27-07-2026

Register as of 26 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.